A detailed history of Russell Investments Group, Ltd. transactions in Cor Medix Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 4,487 shares of CRMD stock, worth $38,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,487
Previous 1,012 343.38%
Holding current value
$38,318
Previous $4,000 800.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.64 - $8.23 $12,649 - $28,599
3,475 Added 343.38%
4,487 $36,000
Q2 2024

Aug 08, 2024

BUY
$4.08 - $6.39 $4,128 - $6,466
1,012 New
1,012 $4,000
Q4 2023

Feb 05, 2024

SELL
$3.0 - $4.01 $132 - $176
-44 Reduced 34.92%
82 $0
Q3 2023

Nov 13, 2023

BUY
$3.6 - $4.46 $453 - $561
126 New
126 $0

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $352M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.